Tag Archives: U.S.

Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma

Print this page ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced that the U.S. Food and Drug Administration (FDA) approved Cabometyx (cabozantinib) tablets for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib. HCC is the most common form of liver cancer and the fastest-rising cause of cancer-related death in… Read More »

U.S. top court rejects Amgen over cholesterol medication patent fight

WASHINGTON (Reuters) – Amgen Inc on Monday lost its bid at the U.S. Supreme Court to overturn a ruling that kept the Regeneron Pharmaceuticals Inc and Sanofi SA cholesterol-lowering drug Praluent on the market, but the patent dispute among the rival drugmakers will continue in another trial. FILE PHOTO: An Amgen sign is seen at… Read More »

Salmonella outbreak linked to raw turkey leaves over 200 sick across U.S.

(Reuters) – More than 200 people from across the United States have fallen ill, 84 of them hospitalized, from an ongoing salmonella outbreak linked to raw turkey products that prompted a second voluntary recall on Friday, the U.S. government said. The latest food-safety advisory from the U.S. Centers for Disease Control and Prevention (CDC) in… Read More »

Widespread, occasional use of antibiotics in U.S. linked with resistance

The increasing prevalence of antibiotic resistance in the U.S. appears more closely linked to their occasional use by many people than to their repeated use among smaller numbers of people, according to a large new study from Harvard T.H. Chan School of Public Health. The study also found that antibiotic use varies across the nation,… Read More »

Olympus unit pleads guilty to resolve U.S. duodenoscope probe

(Reuters) – An Olympus Corp subsidiary pleaded guilty on Monday and agreed to pay $ 85 million to resolve charges that it failed to file reports with U.S. regulators regarding infections connected to its duodenoscopes while continuing to sell the medical devices used to view the gastrointestinal tract. Olympus Medical Systems Corp and Hisao Yabe,… Read More »